Many elderly people suffer from blindness caused due to agerelated macular degeneration. Doctors are evading restrictions on expensive sight-saving drugs by offering patients an unlicensed alternative costing just £10. Eye specialists are prescribing Avastin to elderly blind; the drug is widely used to treat bowel cancer but has not been given a safety license for treating AMD. Lucentis can only be prescribed on the NHS to the worst 20 per cent of cases and only then when they have already lost sight in one eye. Health experts feel that as many people as possible should be treated for wet AMD and to afford it they need to use Avastin. If you have only got one eye affected, the other eye might get something else the next year. But while Lucentis costs more than £700 per injection, Avastin which is made by the same company costs as little as £10 a shot.

More...

Schizophrenia is a very complex and debilitating brain disorder. All current studies that rely on drugs that can only mimic the manifestations of schizophrenia. But researchers from Johns Hopkins took advantage of the recent discovery of a major risk factor for this disease: the DISC1 gene which helped them develop a new mouse based on a genetic change relevant to the disease which would assist in understanding disease progression and developing new therapies. The researchers generated mice that make an incomplete, shortened form of the DISC1 protein which showed behaviors similar to hyperactivity, smell defects and apathy observed in schizophrenia patients.

More...

Technology has no limit; in fact it has made things possible beyond our imagination. Science’s ability has reached such a level in the field of disabled that it can not only get amputees out of wheelchairs but also give them mobility that lets them blend back in into ordinary life. Hydraulic C-LEG’s is an excellent example of latest technology. C-LEG’s CPU brain automatically adapts to changes of speed and direction, and can be pre-programmed into up to 10 switchable modes to enable natural driving, cycling and other programmable activities that require different leg actions to normal walking and stair climbing. The new system will have more sensors, a faster hard drive, more memory, and will offer smooth automatic transitions between common movements such as level-ground walking, climbing stairs and running.

More...

Many elderly people suffer from blindness caused due to agerelated macular degeneration. Doctors are evading restrictions on expensive sight-saving drugs by offering patients an unlicensed alternative costing just £10. Eye specialists are prescribing Avastin to elderly blind; the drug is widely used to treat bowel cancer but has not been given a safety license for treating AMD. Lucentis can only be prescribed on the NHS to the worst 20 per cent of cases and only then when they have already lost sight in one eye. Health experts feel that as many people as possible should be treated for wet AMD and to afford it they need to use Avastin. If you have only got one eye affected, the other eye might get something else the next year. But while Lucentis costs more than £700 per injection, Avastin which is made by the same company costs as little as £10 a shot.

More...

Schizophrenia is a very complex and debilitating brain disorder. All current studies that rely on drugs that can only mimic the manifestations of schizophrenia. But researchers from Johns Hopkins took advantage of the recent discovery of a major risk factor for this disease: the DISC1 gene which helped them develop a new mouse based on a genetic change relevant to the disease which would assist in understanding disease progression and developing new therapies. The researchers generated mice that make an incomplete, shortened form of the DISC1 protein which showed behaviors similar to hyperactivity, smell defects and apathy observed in schizophrenia patients.

More...

Technology has no limit; in fact it has made things possible beyond our imagination. Science’s ability has reached such a level in the field of disabled that it can not only get amputees out of wheelchairs but also give them mobility that lets them blend back in into ordinary life. Hydraulic C-LEG’s is an excellent example of latest technology. C-LEG’s CPU brain automatically adapts to changes of speed and direction, and can be pre-programmed into up to 10 switchable modes to enable natural driving, cycling and other programmable activities that require different leg actions to normal walking and stair climbing. The new system will have more sensors, a faster hard drive, more memory, and will offer smooth automatic transitions between common movements such as level-ground walking, climbing stairs and running.

More...

Many elderly people suffer from blindness caused due to agerelated macular degeneration. Doctors are evading restrictions on expensive sight-saving drugs by offering patients an unlicensed alternative costing just £10. Eye specialists are prescribing Avastin to elderly blind; the drug is widely used to treat bowel cancer but has not been given a safety license for treating AMD. Lucentis can only be prescribed on the NHS to the worst 20 per cent of cases and only then when they have already lost sight in one eye. Health experts feel that as many people as possible should be treated for wet AMD and to afford it they need to use Avastin. If you have only got one eye affected, the other eye might get something else the next year. But while Lucentis costs more than £700 per injection, Avastin which is made by the same company costs as little as £10 a shot.

More...

Schizophrenia is a very complex and debilitating brain disorder. All current studies that rely on drugs that can only mimic the manifestations of schizophrenia. But researchers from Johns Hopkins took advantage of the recent discovery of a major risk factor for this disease: the DISC1 gene which helped them develop a new mouse based on a genetic change relevant to the disease which would assist in understanding disease progression and developing new therapies. The researchers generated mice that make an incomplete, shortened form of the DISC1 protein which showed behaviors similar to hyperactivity, smell defects and apathy observed in schizophrenia patients.

More...

Technology has no limit; in fact it has made things possible beyond our imagination. Science’s ability has reached such a level in the field of disabled that it can not only get amputees out of wheelchairs but also give them mobility that lets them blend back in into ordinary life. Hydraulic C-LEG’s is an excellent example of latest technology. C-LEG’s CPU brain automatically adapts to changes of speed and direction, and can be pre-programmed into up to 10 switchable modes to enable natural driving, cycling and other programmable activities that require different leg actions to normal walking and stair climbing. The new system will have more sensors, a faster hard drive, more memory, and will offer smooth automatic transitions between common movements such as level-ground walking, climbing stairs and running.

More...

Many elderly people suffer from blindness caused due to agerelated macular degeneration. Doctors are evading restrictions on expensive sight-saving drugs by offering patients an unlicensed alternative costing just £10. Eye specialists are prescribing Avastin to elderly blind; the drug is widely used to treat bowel cancer but has not been given a safety license for treating AMD. Lucentis can only be prescribed on the NHS to the worst 20 per cent of cases and only then when they have already lost sight in one eye. Health experts feel that as many people as possible should be treated for wet AMD and to afford it they need to use Avastin. If you have only got one eye affected, the other eye might get something else the next year. But while Lucentis costs more than £700 per injection, Avastin which is made by the same company costs as little as £10 a shot.

More...

Schizophrenia is a very complex and debilitating brain disorder. All current studies that rely on drugs that can only mimic the manifestations of schizophrenia. But researchers from Johns Hopkins took advantage of the recent discovery of a major risk factor for this disease: the DISC1 gene which helped them develop a new mouse based on a genetic change relevant to the disease which would assist in understanding disease progression and developing new therapies. The researchers generated mice that make an incomplete, shortened form of the DISC1 protein which showed behaviors similar to hyperactivity, smell defects and apathy observed in schizophrenia patients.

More...

Technology has no limit; in fact it has made things possible beyond our imagination. Science’s ability has reached such a level in the field of disabled that it can not only get amputees out of wheelchairs but also give them mobility that lets them blend back in into ordinary life. Hydraulic C-LEG’s is an excellent example of latest technology. C-LEG’s CPU brain automatically adapts to changes of speed and direction, and can be pre-programmed into up to 10 switchable modes to enable natural driving, cycling and other programmable activities that require different leg actions to normal walking and stair climbing. The new system will have more sensors, a faster hard drive, more memory, and will offer smooth automatic transitions between common movements such as level-ground walking, climbing stairs and running.

More...

Many elderly people suffer from blindness caused due to agerelated macular degeneration. Doctors are evading restrictions on expensive sight-saving drugs by offering patients an unlicensed alternative costing just £10. Eye specialists are prescribing Avastin to elderly blind; the drug is widely used to treat bowel cancer but has not been given a safety license for treating AMD. Lucentis can only be prescribed on the NHS to the worst 20 per cent of cases and only then when they have already lost sight in one eye. Health experts feel that as many people as possible should be treated for wet AMD and to afford it they need to use Avastin. If you have only got one eye affected, the other eye might get something else the next year. But while Lucentis costs more than £700 per injection, Avastin which is made by the same company costs as little as £10 a shot.

More...

Schizophrenia is a very complex and debilitating brain disorder. All current studies that rely on drugs that can only mimic the manifestations of schizophrenia. But researchers from Johns Hopkins took advantage of the recent discovery of a major risk factor for this disease: the DISC1 gene which helped them develop a new mouse based on a genetic change relevant to the disease which would assist in understanding disease progression and developing new therapies. The researchers generated mice that make an incomplete, shortened form of the DISC1 protein which showed behaviors similar to hyperactivity, smell defects and apathy observed in schizophrenia patients.

More...

Technology has no limit; in fact it has made things possible beyond our imagination. Science’s ability has reached such a level in the field of disabled that it can not only get amputees out of wheelchairs but also give them mobility that lets them blend back in into ordinary life. Hydraulic C-LEG’s is an excellent example of latest technology. C-LEG’s CPU brain automatically adapts to changes of speed and direction, and can be pre-programmed into up to 10 switchable modes to enable natural driving, cycling and other programmable activities that require different leg actions to normal walking and stair climbing. The new system will have more sensors, a faster hard drive, more memory, and will offer smooth automatic transitions between common movements such as level-ground walking, climbing stairs and running.

More...